0001178913-22-002412.txt : 20220621
0001178913-22-002412.hdr.sgml : 20220621
20220621071516
ACCESSION NUMBER: 0001178913-22-002412
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220616
FILED AS OF DATE: 20220621
DATE AS OF CHANGE: 20220621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quigley Jill M.
CENTRAL INDEX KEY: 0001799780
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38807
FILM NUMBER: 221026022
MAIL ADDRESS:
STREET 1: TWO COMMERCE SQUARE, 2001 MARKET STREET
STREET 2: 28TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd.
CENTRAL INDEX KEY: 0001534248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813676773
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
BUSINESS PHONE: 972-77-331-0156
MAIL ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
FORMER COMPANY:
FORMER CONFORMED NAME: Anchiano Therapeutics Ltd.
DATE OF NAME CHANGE: 20180906
FORMER COMPANY:
FORMER CONFORMED NAME: BioCancell Ltd.
DATE OF NAME CHANGE: 20111104
3
1
ownership.xml
X0206
3
2022-06-16
0
0001534248
Chemomab Therapeutics Ltd.
CMMB
0001799780
Quigley Jill M.
C/O CHEMOMAB THERAPEUTICS LTD.
1065 EAST HILLSDALE BLVD., SUITE 100
FOSTER
CA
94404
1
0
0
0
Option to Purchase American Depositary Shares
3.25
2032-06-16
American Depositary Shares
13640
D
Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
These options vest and become exercisable in equal monthly installments over a 36 month period commencing on June 16, 2022, subject to the Reporting Person's continued service.
/s/ Jill M. Quigley
2022-06-21